{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["apoptosis", "hepatocellular carcinoma", "mesoporous silica nanoparticles", "natural pro-drug", "targeted drug delivery"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "29899871", "DateRevised": {"Year": "2024", "Month": "03", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "05", "Day": "29"}], "Language": ["eng"], "ELocationID": ["10.18632/oncotarget.25470"], "Journal": {"ISSN": "1949-2553", "JournalIssue": {"Volume": "9", "Issue": "41", "PubDate": {"Year": "2018", "Month": "May", "Day": "29"}}, "Title": "Oncotarget", "ISOAbbreviation": "Oncotarget"}, "ArticleTitle": "Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action.", "Pagination": {"StartPage": "26466", "EndPage": "26490", "MedlinePgn": "26466-26490"}, "Abstract": {"AbstractText": ["Naturally derived prodrugs have a wide range of pharmacological activities, including anticancer, antioxidant, and antiviral effects. However, significant barriers inhibit their use in medicine, e.g. their hydrophobicity. In this comprehensive study, we investigated simple and effective nanoformulations consisting of amine-functionalized and conjugated with folic acid (FA) mesoporous silica nanoparticles (MSNs). Two types of MSNs were studied: KCC- 1, with mean size 324 nm and mean pore diameter 3.4 nm, and MCM - 41, with mean size 197 and pore diameter 2 nm. Both types of MSNs were loaded with three anticancer prodrugs: curcumin, quercetin, and colchicine. The nanoformulations were tested to target <i>in vitro</i> human hepatocellular carcinoma cells (HepG2) and HeLa cancer cells. The amine-functionalized and FA-conjugated curcumin-loaded, especially KCC-1 MSNs penetrated all cells organs and steadily released curcumin. The FA-conjugated MSNs displayed higher cellular uptake, sustained intracellular release, and cytotoxicity effects in comparison to non-conjugated MSNs. The KCC-1 type MSNs carrying curcumin displayed the highest anticancer activity. Apoptosis was induced through specific signaling molecular pathways (caspase-3, H<sub>2</sub>O<sub>2</sub>, c-MET, and MCL-1). The nanoformulations displayed also an enhanced antioxidant activity compared to the pure forms of the prodrugs, and the effect depended on the time of release, type of MSN, prodrug, and assay used. FA-conjugated MSNs carrying curcumin and other safe natural prodrugs offer new possibilities for targeted cancer therapy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal and Aromatic Plants Research, Pharmaceutical and Drug Industries Research Division, National Research Centre (NRC), Dokki, Giza, Egypt."}, {"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}], "LastName": "AbouAitah", "ForeName": "Khaled", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}], "LastName": "Swiderska-Sroda", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Materials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, Beni-Suef, Egypt."}], "LastName": "Farghali", "ForeName": "Ahmed A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}], "LastName": "Wojnarowicz", "ForeName": "Jacek", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Engineering Laboratory, Faculty of Chemical and Process Engineering, Warsaw University of Technology, Warsaw, Poland."}], "LastName": "Stefanek", "ForeName": "Agata", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}], "LastName": "Gierlotka", "ForeName": "Stanislaw", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}], "LastName": "Opalinska", "ForeName": "Agnieszka", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Environmental Virology Laboratory, National Research Centre (NRC), Dokki, Giza, Egypt."}], "LastName": "Allayeh", "ForeName": "Abdou K", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Engineering Laboratory, Faculty of Chemical and Process Engineering, Warsaw University of Technology, Warsaw, Poland."}], "LastName": "Ciach", "ForeName": "Tomasz", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}], "LastName": "Lojkowski", "ForeName": "Witold", "Initials": "W"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oncotarget", "NlmUniqueID": "101532965", "ISSNLinking": "1949-2553"}, "CoiStatement": "CONFLICTS OF INTEREST The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Sanna V, Pala N, Sechi M. Targeted therapy using nanotechnology: focus on cancer. International Journal of Nanomedicine. 2014;9:467\u201383.", "ArticleIdList": ["PMC3896284", "24531078"]}, {"Citation": "Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nano. 2007;2:751\u201360.", "ArticleIdList": ["18654426"]}, {"Citation": "Goldsmith M, Abramovitz L, Peer D. Precision nanomedicine in neurodegenerative diseases. ACS Nano. 2014;8:1958\u201365.", "ArticleIdList": ["24660817"]}, {"Citation": "Min Y, Caster JM, Eblan MJ, Wang AZ. Clinical Translation of Nanomedicine. Chemical Reviews. 2015;115:11147\u201390.", "ArticleIdList": ["PMC4607605", "26088284"]}, {"Citation": "Ambrogio MW, Thomas CR, Zhao YL, Zink JI, Stoddart JF. Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine. Acc Chem Res. 2011;44:903\u201313.", "ArticleIdList": ["PMC3196789", "21675720"]}, {"Citation": "Tang L, Cheng J. Nonporous silica nanoparticles for nanomedicine application. Nano Today. 2013;8:290\u2013312.", "ArticleIdList": ["PMC3757135", "23997809"]}, {"Citation": "Oussoren C, Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev. 2001;50:143\u201356.", "ArticleIdList": ["11489337"]}, {"Citation": "Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric Systems for Controlled Drug Release. Chemical Reviews. 1999;99:3181\u201398.", "ArticleIdList": ["11749514"]}, {"Citation": "Wang X, Li X, Ito A, Sogo Y, Ohno T. Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy. Acta Biomater. 2013;9:7480\u20139.", "ArticleIdList": ["23541601"]}, {"Citation": "Watermann A, Brieger J. Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer. Nanomaterials (Basel) 2017;7:E189.", "ArticleIdList": ["PMC5535255", "28737672"]}, {"Citation": "Wen J, Yang K, Liu F, Li H, Xu Y, Sun S. Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems. Chemical Society Reviews. 2017;46:6024\u201345.", "ArticleIdList": ["28848978"]}, {"Citation": "Benezra M, Penate-Medina O, Zanzonico PB, Schaer D, Ow H, Burns A, DeStanchina E, Longo V, Herz E, Iyer S, Wolchok J, Larson SM, Wiesner U, et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. The Journal of Clinical Investigation. 2011;121:2768\u201380.", "ArticleIdList": ["PMC3223837", "21670497"]}, {"Citation": "Quan G, Pan X, Wang Z, Wu Q, Li G, Dian L, Chen B, Wu C. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery. Journal of Nanobiotechnology. 2015;13:1\u201312.", "ArticleIdList": ["PMC4333889", "25643602"]}, {"Citation": "Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed Engl. 2007;46:7548\u201358.", "ArticleIdList": ["17854012"]}, {"Citation": "Natarajan SK, Selvaraj S. Mesoporous silica nanoparticles: importance of surface modifications and its role in drug delivery. RSC Advances. 2014;4:14328\u201334."}, {"Citation": "Yang H, Lou C, Xu M, Wu C, Miyoshi H, Liu Y. Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism. Int J Nanomedicine. 2011;6:2023\u201332.", "ArticleIdList": ["PMC3181061", "21976977"]}, {"Citation": "Weinstein SJ, Hartman TJ, Stolzenberg-Solomon R, Pietinen P, Barrett MJ, Taylor PR, Virtamo J, Albanes D. Null Association between Prostate Cancer and Serum Folate, Vitamin B6, Vitamin B12, and Homocysteine. Cancer Epidemiology Biomarkers & Prevention. 2003;12:1271\u20132.", "ArticleIdList": ["14652294"]}, {"Citation": "Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev. 2002;54:675\u201393.", "ArticleIdList": ["12204598"]}, {"Citation": "Porta F, Lamers GEM, Morrhayim J, Chatzopoulou A, Schaaf M, den Dulk H, Backendorf C, Zink JI, Kros A. Folic Acid-Modified Mesoporous Silica Nanoparticles for Cellular and Nuclear Targeted Drug Delivery. Advanced Healthcare Materials. 2013;2:281\u20136.", "ArticleIdList": ["23184490"]}, {"Citation": "Rosenholm JM, Meinander A, Peuhu E, Niemi R, Eriksson JE, Sahlgren C, Linden M. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano. 2009;3:197\u2013206.", "ArticleIdList": ["19206267"]}, {"Citation": "Senthilkumar R, Karaman DS, Paul P, Bjork EM, Oden M, Eriksson JE, Rosenholm JM. Targeted delivery of a novel anticancer compound anisomelic acid using chitosan-coated porous silica nanorods for enhancing the apoptotic effect. Biomater Sci. 2015;3:103\u201311.", "ArticleIdList": ["26214194"]}, {"Citation": "El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118\u201327.", "ArticleIdList": ["21992124"]}, {"Citation": "Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25\u201334.", "ArticleIdList": ["19095497"]}, {"Citation": "Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res. 2009;15:1126\u201332.", "ArticleIdList": ["PMC3182268", "19228717"]}, {"Citation": "Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 2005;55:178\u201394.", "ArticleIdList": ["15890640"]}, {"Citation": "Baig S, Seevasant I, Mohamad J, Mukheem A, Huri HZ, Kamarul T. Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand? Cell Death & Disease. 2016;7:e2058.", "ArticleIdList": ["PMC4816162", "26775709"]}, {"Citation": "Shi M, Lu XJ, Zhang J, Diao H, Li G, Xu L, Wang T, Wei J, Meng W, Ma JL, Yu H, Wang YG. Oridonin, a novel lysine acetyltransferases inhibitor, inhibits proliferation and induces apoptosis in gastric cancer cells through p53- and caspase-3-mediated mechanisms. Oncotarget. 2016;7:22623\u201331.  https://doi.org/10.18632/oncotarget.8033.", "ArticleIdList": ["10.18632/oncotarget.8033", "PMC5008386", "26980707"]}, {"Citation": "Yu Q, Liu ZY, Chen Q, Lin JS. Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma. J Huazhong Univ Sci Technolog Med Sci. 2016;36:494\u2013500.", "ArticleIdList": ["27465322"]}, {"Citation": "Jiang X, Feng K, Zhang Y, Li Z, Zhou F, Dou H, Wang T. Sorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinoma. Oncotarget. 2015;6:12340\u201356.  https://doi.org/10.18632/oncotarget.3656.", "ArticleIdList": ["10.18632/oncotarget.3656", "PMC4494942", "25895026"]}, {"Citation": "Wlassoff WA, Albright CD, Sivashinski MS, Ivanova A, Appelbaum JG, Salganik RI. Hydrogen peroxide overproduced in breast cancer cells can serve as an anticancer prodrug generating apoptosis-stimulating hydroxyl radicals under the effect of tamoxifen-ferrocene conjugate. J Pharm Pharmacol. 2007;59:1549\u201353.", "ArticleIdList": ["17976267"]}, {"Citation": "Kumar SV, Saravanan D, Kumar B, Jayakumar A. An update on prodrugs from natural products. Asian Pacific Journal of Tropical Medicine. 2014;7:S54\u2013S9.", "ArticleIdList": ["25312180"]}, {"Citation": "Ouyang L, Luo Y, Tian M, Zhang SY, Lu R, Wang JH, Kasimu R, Li X. Plant natural products: from traditional compounds to new emerging drugs in cancer therapy. Cell Prolif. 2014;47:506\u201315.", "ArticleIdList": ["PMC6496831", "25377084"]}, {"Citation": "Pistollato F, Giampieri F, Battino M. The use of plant-derived bioactive compounds to target cancer stem cells and modulate tumor microenvironment. Food and Chemical Toxicology. 2015;75:58\u201370.", "ArticleIdList": ["25445513"]}, {"Citation": "Bharali DJ, Siddiqui IA, Adhami VM, Chamcheu JC, Aldahmash AM, Mukhtar H, Mousa SA. Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects. Cancers. 2011;3:4024.", "ArticleIdList": ["PMC3763408", "24213123"]}, {"Citation": "Gunasekaran T, Haile T, Nigusse T, Dhanaraju MD. Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine. Asian Pacific Journal of Tropical Biomedicine. 2014;4:S1\u2013S7.", "ArticleIdList": ["PMC4025268", "25183064"]}, {"Citation": "Watkins R, Wu L, Zhang C, Davis RM, Xu B. Natural product-based nanomedicine: recent advances and issues. Int J Nanomedicine. 2015;10:6055\u201374.", "ArticleIdList": ["PMC4592057", "26451111"]}, {"Citation": "Salem M, Rohani S, Gillies ER. Curcumin, a promising anti-cancer therapeutic: a review of its chemical properties, bioactivity and approaches to cancer cell delivery. RSC Advances. 2014;4:10815\u201329."}, {"Citation": "Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011;10:12.", "ArticleIdList": ["PMC3055228", "21299897"]}, {"Citation": "Thangasamy T, Sittadjody S, Burd R. Chapter 27-Quercetin: A Potential Complementary and Alternative Cancer Therapy A2-Watson, Ronald Ross. Complementary and Alternative Therapies and the Aging Population. San Diego: Academic Press; 2009. pp. 563\u201384."}, {"Citation": "Gibellini L, Pinti M, Nasi M, Montagna JP, De Biasi S, Roat E, Bertoncelli L, Cooper EL, Cossarizza A. Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med. 2011;2011:591356.", "ArticleIdList": ["PMC3136711", "21792362"]}, {"Citation": "Lange U, Schumann C, Schmidt KL. Current aspects of colchicine therapy \u2014 classical indications and new therapeutic uses. Eur J Med Res. 2001;6:150\u201360.", "ArticleIdList": ["11309227"]}, {"Citation": "Huczynski A, Rutkowski J, Popiel K, Maj E, Wietrzyk J, Stefanska J, Majcher U, Bartl F. Synthesis, antiproliferative and antibacterial evaluation of C-ring modified colchicine analogues. Eur J Med Chem. 2015;90:296\u2013301.", "ArticleIdList": ["25437616"]}, {"Citation": "AbouAitah KEA, Farghali AA, Swiderska-Sroda A, Lojkowski W, Razin AM, Khedr MK. pH-controlled Release System for Curcumin based on Functionalized Dendritic Mesoporous Silica Nanoparticles. Journal of Nanomedicine & Nanotechnology. 2016;7:1:1\u201311."}, {"Citation": "AbouAitah KEA, Farghali AA, Swiderska-Sroda A, Lojkowski W, Razin AM, Khedr MK. Mesoporous Silica Materials in Drug Delivery System: pH/Glutathione-Responsive Release of Poorly Water-Soluble Pro-drug Quercetin from Two and Three-dimensional Pore-Structure Nanoparticles. Journal of Nanomedicine & Nanotechnology. 2016;7:1:1\u201312."}, {"Citation": "Organ SL, Tsao MS. An overview of the c-MET signaling pathway. Ther Adv Med Oncol. 2011;3:S7\u2013S19.  https://doi.org/10.1177/1758834011422556.", "ArticleIdList": ["10.1177/1758834011422556", "PMC3225017", "22128289"]}, {"Citation": "Akgul C. Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci. 2009;66:1326\u201336.", "ArticleIdList": ["19099185"]}, {"Citation": "Antonio E, Khalil NM, Mainardes RM. Bovine Serum Albumin Nanoparticles Containing Quercetin: Characterization and Antioxidant Activity. J Nanosci Nanotechnol. 2016;16:1346\u201353.", "ArticleIdList": ["27433585"]}, {"Citation": "Huang X, Huang X, Gong Y, Xiao H, McClements DJ, Hu K. Enhancement of curcumin water dispersibility and antioxidant activity using core\u2013shell protein\u2013polysaccharide nanoparticles. Food Research International. 2016;87:1\u20139.", "ArticleIdList": ["29606228"]}, {"Citation": "Huang X, Dai Y, Cai J, Zhong N, Xiao H, McClements DJ, Hu K. Resveratrol encapsulation in core-shell biopolymer nanoparticles: Impact on antioxidant and anticancer activities. Food Hydrocolloids. 2017;64:157\u201365."}, {"Citation": "Mani G, Pushparaj H, Peng MM, Muthiahpillai P, Udhumansha U, Jang HT. Synthesis and characterization of pharmaceutical surfactant templated mesoporous silica: Its application to controlled delivery of duloxetine. Materials Research Bulletin. 2014;51:228\u201335."}, {"Citation": "Wu C, Sun X, Zhao Z, Zhao Y, Hao Y, Liu Y, Gao Y. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs. Materials Science and Engineering: C. 2014;44:262\u20137.", "ArticleIdList": ["25280705"]}, {"Citation": "Zhu W, Wan L, Zhang C, Gao Y, Zheng X, Jiang T, Wang S. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: Influence of pore size on release rate. Materials Science and Engineering: C. 2014;34:78\u201385.", "ArticleIdList": ["24268236"]}, {"Citation": "Horcajada P, M\u00e1rquez-Alvarez C, R\u00e1mila A, P\u00e9rez-Pariente J, Vallet-Reg\u00ed M. Controlled release of Ibuprofen from dealuminated faujasites. Solid State Sciences. 2006;8:1459\u201365."}, {"Citation": "Jambhrunkar S, Qu Z, Popat A, Yang J, Noonan O, Acauan L, Ahmad Nor Y, Yu C, Karmakar S. Effect of surface functionality of silica nanoparticles on cellular uptake and cytotoxicity. Mol Pharm. 2014;11:3642\u201355.", "ArticleIdList": ["25166282"]}, {"Citation": "Guo Z, Liu XM, Ma L, Li J, Zhang H, Gao YP, Yuan Y. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement. Colloids and Surfaces B: Biointerfaces. 2013;101:228\u201335.", "ArticleIdList": ["23010024"]}, {"Citation": "Mu\u00f1oz B, R\u00e1mila A, P\u00e9rez-Pariente J, D\u00edaz I, Vallet-Reg\u00ed M. MCM-41 Organic Modification as Drug Delivery Rate Regulator. Chemistry of Materials. 2003;15:500\u20133."}, {"Citation": "Chung TH, Wu SH, Yao M, Lu CW, Lin YS, Hung Y, Mou CY, Chen YC, Huang DM. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials. 2007;28:2959\u201366.", "ArticleIdList": ["17397919"]}, {"Citation": "Lee CH, Lo LW, Mou CY, Yang CS. Synthesis and Characterization of Positive-Charge Functionalized Mesoporous Silica Nanoparticles for Oral Drug Delivery of an Anti-Inflammatory Drug. Advanced Functional Materials. 2008;18:3283\u201392."}, {"Citation": "Wani A, Muthuswamy E, Savithra GL, Mao G, Brock S, Oupick\u00fd D. Surface Functionalization of Mesoporous Silica Nanoparticles Controls Loading and Release Behavior of Mitoxantrone. Pharmaceutical Research. 2012;29:2407\u201318.", "ArticleIdList": ["22555380"]}, {"Citation": "Yoncheva K, Popova M, Szegedi A, Mihaly J, Tzankov B, Lambov N, Konstantinov S, Tzankova V, Pessina F, Valoti M. Functionalized mesoporous silica nanoparticles for oral delivery of budesonide. Journal of Solid State Chemistry. 2014;211:154\u201361."}, {"Citation": "Pang J, Zhao L, Zhang L, Li Z, Luan Y. Folate-conjugated hybrid SBA-15 particles for targeted anticancer drug delivery. J Colloid Interface Sci. 2013;395:31\u20139.", "ArticleIdList": ["23312579"]}, {"Citation": "Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Nanotechnology. 2011;22:455102.", "ArticleIdList": ["22019849"]}, {"Citation": "Heidari A, Younesi H, Mehraban Z. Removal of Ni(II), Cd(II), and Pb(II) from a ternary aqueous solution by amino functionalized mesoporous and nano mesoporous silica. Chemical Engineering Journal. 2009;153:70\u20139."}, {"Citation": "Feng W, Nie W, He C, Zhou X, Chen L, Qiu K, Wang W, Yin Z. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers. ACS Appl Mater Interfaces. 2014;6:8447\u201360.", "ArticleIdList": ["24745551"]}, {"Citation": "Vallhov H, Gabrielsson S, Stromme M, Scheynius A, Garcia-Bennett AE. Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Lett. 2007;7:3576\u201382.", "ArticleIdList": ["17975942"]}, {"Citation": "Luo Z, Cai K, Hu Y, Zhang B, Xu D. Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity. Adv Healthc Mater. 2012;1:321\u20135.", "ArticleIdList": ["23184747"]}, {"Citation": "Luo Z, Ding X, Hu Y, Wu S, Xiang Y, Zeng Y, Zhang B, Yan H, Zhang H, Zhu L, Liu J, Li J, Cai K, et al. Engineering a Hollow Nanocontainer Platform with Multifunctional Molecular Machines for Tumor-Targeted Therapy in Vitro and in Vivo. ACS Nano. 2013;7:10271\u201384.", "ArticleIdList": ["24127723"]}, {"Citation": "Zhang Q, Liu F, Nguyen KT, Ma X, Wang X, Xing B, Zhao Y. Multifunctional Mesoporous Silica Nanoparticles for Cancer-Targeted and Controlled Drug Delivery. Advanced Functional Materials. 2012;22:5144\u201356."}, {"Citation": "Jiao Y, Shen S, Sun Y, Jiang X, Yang W. A Functionalized Hollow Mesoporous Silica Nanoparticles-Based Controlled Dual-Drug Delivery System for Improved Tumor Cell Cytotoxicity. Particle & Particle Systems Characterization. 2015;32:222\u201333."}, {"Citation": "Gayam SR, Wu SP. Redox responsive Pd(ii) templated rotaxane nanovalve capped mesoporous silica nanoparticles: a folic acid mediated biocompatible cancer-targeted drug delivery system. Journal of Materials Chemistry B. 2014;2:7009\u201316.", "ArticleIdList": ["32262111"]}, {"Citation": "Sattar R, Ali SA, Abbasi A. Molecular mechanism of apoptosis: prediction of three-dimensional structure of caspase-6 and its interactions by homology modeling. Biochemical and Biophysical Research Communications. 2003;308:497\u2013504.", "ArticleIdList": ["12914778"]}, {"Citation": "Tahmasebi Mirgani M, Isacchi B, Sadeghizadeh M, Marra F, Bilia AR, Mowla SJ, Najafi F, Babaei E. Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells. Int J Nanomedicine. 2014;9:403\u201317.", "ArticleIdList": ["PMC3894954", "24531649"]}, {"Citation": "Li J, Chen T, Deng F, Wan J, Tang Y, Yuan P, Zhang L. Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid. Int J Nanomedicine. 2015;10:5475\u201387.", "ArticleIdList": ["PMC4556296", "26346750"]}, {"Citation": "Lopez-Lazaro M. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett. 2007;252:1\u20138.", "ArticleIdList": ["17150302"]}, {"Citation": "Zhang L, Li J, Zong L, Chen X, Chen K, Jiang Z, Nan L, Li X, Li W, Shan T, Ma Q, Ma Z. Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer. Oxid Med Cell Longev. 2016;2016:1616781.", "ArticleIdList": ["PMC4735911", "26881012"]}, {"Citation": "Liu J, Wang Z. Increased Oxidative Stress as a Selective Anticancer Therapy. Oxid Med Cell Longev. 2015;2015:294303.", "ArticleIdList": ["PMC4529973", "26273420"]}, {"Citation": "Wagner BA, Evig CB, Reszka KJ, Buettner GR, Burns CP. Doxorubicin increases intracellular hydrogen peroxide in PC3 prostate cancer cells. Arch Biochem Biophys. 2005;440:181\u201390.", "ArticleIdList": ["PMC4538991", "16054588"]}, {"Citation": "Itoh T, Terazawa R, Kojima K, Nakane K, Deguchi T, Ando M, Tsukamasa Y, Ito M, Nozawa Y. Cisplatin induces production of reactive oxygen species via NADPH oxidase activation in human prostate cancer cells. Free Radic Res. 2011;45:1033\u20139.", "ArticleIdList": ["21682664"]}, {"Citation": "Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 2008;48:1312\u201327.", "ArticleIdList": ["PMC2597642", "18821591"]}, {"Citation": "Hu HJ, Lin XL, Liu MH, Fan XJ, Zou WW. Curcumin mediates reversion of HGF-induced epithelial-mesenchymal transition via inhibition of c-Met expression in DU145 cells. Oncol Lett. 2016;11:1499\u2013505.", "ArticleIdList": ["PMC4734299", "26893768"]}, {"Citation": "You H, Ding W, Dang H, Jiang Y, Rountree CB. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology. 2011;54:879\u201389.", "ArticleIdList": ["PMC3181384", "21618573"]}, {"Citation": "Jung HY, Joo HJ, Park JK, Kim YH. The Blocking of c-Met Signaling Induces Apoptosis through the Increase of p53 Protein in Lung Cancer. Cancer Research and Treatment. 2012;44:251\u201361.", "ArticleIdList": ["PMC3546272", "23341789"]}, {"Citation": "Warr MR, Shore GC. Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med. 2008;8:138\u201347.", "ArticleIdList": ["18336294"]}, {"Citation": "Polier G, Ding J, Konkimalla BV, Eick D, Ribeiro N, K\u00f6hler R, Giaisi M, Efferth T, Desaubry L, Krammer PH, Li-Weber M. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Cell Death & Disease. 2011;2:e182.", "ArticleIdList": ["PMC3199715", "21776020"]}, {"Citation": "Chen Y, Wu Y, He J, Chen W. The experimental and clinical study on the effect of curcumin on cell cycle proteins and regulating proteins of apoptosis in acute myelogenous leukemia. J Huazhong Univ Sci Technolog Med Sci. 2002;22:295\u20138.", "ArticleIdList": ["12674762"]}, {"Citation": "Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans. 2007;35:1147\u201350.", "ArticleIdList": ["17956298"]}, {"Citation": "Lu J, Li Z, Zink JI, Tamanoi F. In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification. Nanomedicine. 2012;8:212\u201320.", "ArticleIdList": ["PMC3221805", "21703996"]}, {"Citation": "Polshettiwar V, Cha D, Zhang X, Basset JM. High-Surface-Area Silica Nanospheres (KCC-1) with a Fibrous Morphology. Angewandte Chemie (International Ed. In English) 2010;49:9652\u20136.", "ArticleIdList": ["20680958"]}, {"Citation": "Ritter H, Ramm JH, Br\u00fchwiler D. Influence of the Structural Properties of Mesoporous Silica on the Adsorption of Guest Molecules. Materials. 2010;3:4500.", "ArticleIdList": ["PMC5445832", "28883338"]}, {"Citation": "Huang X, Tao Z, Praskavich JC, Goswami A, Al-Sharab JF, Minko T, Polshettiwar V, Asefa T. Dendritic Silica Nanomaterials (KCC-1) with Fibrous Pore Structure Possess High DNA Adsorption Capacity and Effectively Deliver Genes In Vitro. Langmuir. 2014;30:10886\u201398.", "ArticleIdList": ["25188675"]}, {"Citation": "Limnell T, Santos HA, Makila E, Heikkila T, Salonen J, Murzin DY, Kumar N, Laaksonen T, Peltonen L, Hirvonen J. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. J Pharm Sci. 2011;100:3294\u2013306.", "ArticleIdList": ["21520084"]}, {"Citation": "Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55\u201363.", "ArticleIdList": ["6606682"]}, {"Citation": "Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. LWT - Food Science and Technology. 1995;28:25\u201330."}, {"Citation": "Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999;26:1231\u20137.", "ArticleIdList": ["10381194"]}, {"Citation": "Assaad HI, Zhou L, Carroll RJ, Wu G. Rapid publication-ready MS-Word tables for one-way ANOVA. SpringerPlus. 2014;3:474.", "ArticleIdList": ["PMC4153873", "25191639"]}]}], "History": [{"Year": "2018", "Month": "2", "Day": "23"}, {"Year": "2018", "Month": "5", "Day": "1"}, {"Year": "2018", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "15", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "5", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["29899871", "PMC5995188", "10.18632/oncotarget.25470", "25470"]}}]}